Literature DB >> 15456685

Executive functions in children aged 6 to 13: a dimensional and developmental study.

Karin C Brocki1, Gunilla Bohlin.   

Abstract

A cross-sectional study using 92 children aged 6 to 13 years investigated the dimensionality and the development of executive functioning. The measures were drawn from developmentally relevant conceptualizations of executive functioning and included a go/no-go task, a verbal fluency task, a continuous performance task, a Stroop-like task, a hand movements task, and a digit span task. Analyses revealed 3 dimensions interpreted as Disinhibition, Speed/arousal, and Working memory/Fluency. Age and sex differences were analyzed for the delineated functions, which means that the results may be taken to represent age effects at the level of specific processes within the executive domain rather than on single tests. Age-dependent changes in children's performance on all 3 dimensions were demonstrated, with 3 particularly active stages of maturation: early childhood (6-8 years of age), middle childhood (9-12 years of age), and during early adolescence. Sex differences were only found for the speed/arousal dimension. The results are discussed in terms of 2 developmental executive function frameworks (Barkley, 1997b; Roberts & Pennington, 1996), where inhibition and the interaction between inhibition and working memory, respectively, are seen as key in the development of executive functioning.

Entities:  

Mesh:

Year:  2004        PMID: 15456685     DOI: 10.1207/s15326942dn2602_3

Source DB:  PubMed          Journal:  Dev Neuropsychol        ISSN: 1532-6942            Impact factor:   2.253


  117 in total

1.  Working memory, attention, inhibition, and their relation to adaptive functioning and behavioral/emotional symptoms in school-aged children.

Authors:  Virve Vuontela; Synnöve Carlson; Anna-Maria Troberg; Tuija Fontell; Petteri Simola; Suvi Saarinen; Eeva T Aronen
Journal:  Child Psychiatry Hum Dev       Date:  2013-02

Review 2.  A developmental perspective on executive function.

Authors:  John R Best; Patricia H Miller
Journal:  Child Dev       Date:  2010 Nov-Dec

Review 3.  Physical activity interventions and children's mental function: an introduction and overview.

Authors:  Phillip D Tomporowski; Kate Lambourne; Michelle S Okumura
Journal:  Prev Med       Date:  2011-03-21       Impact factor: 4.018

Review 4.  Neurobiological processes in adolescent addictive disorders.

Authors:  Ty S Schepis; Bryon Adinoff; Uma Rao
Journal:  Am J Addict       Date:  2008 Jan-Feb

5.  Functional developmental similarities and differences in the neural correlates of verbal and nonverbal working memory tasks.

Authors:  Shefali B Brahmbhatt; Tara McAuley; Deanna M Barch
Journal:  Neuropsychologia       Date:  2007-11-22       Impact factor: 3.139

6.  Age-related differences in executive function among children with spina bifida/hydrocephalus based on parent behavior ratings.

Authors:  Reem A Tarazi; T Andrew Zabel; E Mark Mahone
Journal:  Clin Neuropsychol       Date:  2007-08-18       Impact factor: 3.535

7.  A Longitudinal Assessment of the Relation between Executive Function and Theory of Mind at 3, 4, and 5 Years.

Authors:  Stuart Marcovitch; Marion O'Brien; Susan D Calkins; Esther M Leerkes; Jennifer M Weaver; Douglas W Levine
Journal:  Cogn Dev       Date:  2015 January-March

Review 8.  The elusive nature of executive functions: a review of our current understanding.

Authors:  María Beatriz Jurado; Mónica Rosselli
Journal:  Neuropsychol Rev       Date:  2007-09-05       Impact factor: 7.444

Review 9.  Assessment of attention in preschoolers.

Authors:  E M Mahone; H E Schneider
Journal:  Neuropsychol Rev       Date:  2012-10-23       Impact factor: 7.444

10.  No relationship between neurocognitive functioning and mild sleep disordered breathing in a community sample of children.

Authors:  Susan L Calhoun; Susan D Mayes; Alexandros N Vgontzas; Marina Tsaoussoglou; Laura J Shifflett; Edward O Bixler
Journal:  J Clin Sleep Med       Date:  2009-06-15       Impact factor: 4.062

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.